Hiv-1 Infection Market Share, Key Trends, Regional Outlook & Forecasts to 2016
- Submitted by: sank
- Views: 101
- Category: Other
- Date Submitted: 02/23/2016 03:09 AM
- Pages: 2
- Report this Essay
HIV-1 Infection market, Key Trends, Application Analysis, Regional Outlook & Forecasts to 2016
Global Markets Direct's, 'HIV-1 Infection - Pipeline Review, H2 2015', provides an overview of the HIV-1 Infection's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/hiv-1-infection-pipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Table Of Content
Table Of Contents 2
Introduction 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/145813
HIV-1 Infection Overview 7
Therapeutics Development 8
HIV-1 Infection - Therapeutics under Development by Companies 10
HIV-1 Infection - Therapeutics under Investigation by Universities/Institutes 15
HIV-1 Infection - Pipeline Products Glance 19
HIV-1 Infection - Products under Development by Companies 22
HIV-1 Infection - Products under...
Global Markets Direct's, 'HIV-1 Infection - Pipeline Review, H2 2015', provides an overview of the HIV-1 Infection's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/hiv-1-infection-pipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Table Of Content
Table Of Contents 2
Introduction 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/145813
HIV-1 Infection Overview 7
Therapeutics Development 8
HIV-1 Infection - Therapeutics under Development by Companies 10
HIV-1 Infection - Therapeutics under Investigation by Universities/Institutes 15
HIV-1 Infection - Pipeline Products Glance 19
HIV-1 Infection - Products under Development by Companies 22
HIV-1 Infection - Products under...